Details of Drug

Drug General Information (ID: D1699)
Drug Name	Vincristine (liposome)
Drug Type	Small molecule
Drug Synonymous	LCR; Leurocristine; Marqibo; Oncovine; Tecnocris; VCR; VIN; Vincasar; Vincristina; Vincristinum; Vincrstine; Vincrystine; Vinkristin; Indole alkaloid; Liposomal Vincristine; Onco TCS; Vincristina [DCIT]; Oncovin (TN); Tecnocris (TN); Vincristine (INN); Vincristine [INN:BAN]; Vincristinum [INN-Latin]; Lilly37231 (1:1 sulfate salt); Oncovin (1:1 sulfate salt); Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Z-D-Val-Lys(Z)-OH; 22-Oxovincaleukoblastine Click to Show/Hide
Disease Class	2A85: Mature B-cell lymphoma
Therapeutic Class	Antineoplastics
Structure
Structure	3D Structure		2D Structure
Formula	C46H56N4O10
InChI	1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28-,37+,38-,39-,42+,43-,44-,45+,46+/m1/s1
InChIKey	OGWKCGZFUXNPDA-XQKSVPLYSA-N
Canonical SMILES	CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
External Link
	Pubchem ID	5978
	CAS Number	57-22-7
	CHEBI ID	28445
	TTD ID	D09QVV
	VARIDT ID	DR00143

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM006 Altered intestinal mucosa BM010 Transporter inhibition BM011 Transporter induction BM012 Competitive inhibition of transporters BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM024 Competitive inhibition of metabolic enzyme BM043 Additive immunosuppressive effects BM044 Additive myelosuppressive effects BM047 Additive thrombogenic effects BM055 Increased risk of hepatotoxicity BM067 Increased risk of hyponatremia BM074 Increased risk of peripheral neuropathy BM100 Antagonize the effect of vaccine/toxoid BM105 Antagonize the effect of probiotics BM106 Diminish the response to diagnostic skin test antigens BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Vincristine (liposome)
Affected gastrointestinal absorption
	Altered intestinal mucosa					Drug Num: 15
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0491		Digoxin	C41H64O14	2724385	Moderate		Inter Info	[50], [51], [52]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Minor		Inter Info	[198]
D0573		Enoxacin	C15H17FN4O3	3229	Minor		Inter Info	[198]
D1092		Moxifloxacin	C21H24FN3O4	152946	Minor		Inter Info	[198]
D0340		Cinoxacin	C12H10N2O5	2762	Minor		Inter Info	[198]
D0438		Delafloxacin	C18H12ClF3N4O4	487101	Minor		Inter Info	[198]
D0712		Gatifloxacin	C19H22FN3O4	5379	Minor		Inter Info	[198]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Minor		Inter Info	[198]
D0919		Levofloxacin	C18H20FN3O4	149096	Minor		Inter Info	[198]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Minor		Inter Info	[198]
D1102		Nalidixic acid	C12H12N2O3	4421	Minor		Inter Info	[198]
D1155		Norfloxacin	C16H18FN3O3	4539	Minor		Inter Info	[198]
D1165		Ofloxacin	C18H20FN3O4	4583	Minor		Inter Info	[198]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Minor		Inter Info	[198]
D1657		Trovafloxacin	C20H15F3N4O3	62959	Minor		Inter Info	[198]
Affected cellular transport
	Transporter inhibition					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[45], [46], [47]
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[4], [89], [90]
D0251		Capmatinib	C23H17FN6O	25145656	Moderate		Inter Info	[112]
D0408		Daclatasvir	C40H50N8O6	25154714	Moderate		Inter Info	[4], [118]
D0590		Erdafitinib	C25H30N6O2	67462786	Moderate		Inter Info	[133]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[15], [4], [144]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[153]
D1423		Rolapitant	C25H26F6N2O2	10311306	Moderate		Inter Info	[181]
D1608		Tolvaptan	C26H25ClN2O3	216237	Moderate		Inter Info	[15], [4], [194]
	Competitive inhibition of transporters					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1791		Gadobenic acid	C22H28GdN3O11	9852779	Moderate		Inter Info	[141], [142]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 59
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[8], [9], [10]
D0799		Indinavir	C36H47N5O4	5362440	Major		Inter Info	[8], [9], [10]
D1119		Nelfinavir	C32H45N3O4S	64143	Major		Inter Info	[8], [9], [10]
D1415		Ritonavir	C37H48N6O5S2	392622	Major		Inter Info	[8], [9], [10]
D0080		Amprenavir	C25H35N3O6S	65016	Major		Inter Info	[8], [9], [10]
D0116		Atazanavir	C38H52N6O7	148192	Major		Inter Info	[8], [9], [10]
D0192		Boceprevir	C27H45N5O5	10324367	Major		Inter Info	[8], [9], [10]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[8], [9], [10]
D0349		Clarithromycin	C38H69NO13	84029	Major		Inter Info	[8], [9], [10]
D0375		Cobicistat	C40H53N7O5S2	25151504	Major		Inter Info	[8], [9], [10]
D0386		Conivaptan	C32H26N4O2	151171	Major		Inter Info	[8], [9], [10]
D0439		Delavirdine	C22H28N6O3S	5625	Major		Inter Info	[8], [9], [10]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Major		Inter Info	[8], [9], [10]
D0789		Idelalisib	C22H18FN7O	11625818	Major		Inter Info	[8], [9], [10]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Major		Inter Info	[8], [9], [10]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Major		Inter Info	[8], [9], [10]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Major		Inter Info	[8], [9], [10]
D1117		Nefazodone	C25H32ClN5O2	4449	Major		Inter Info	[8], [9], [10]
D1315		Posaconazole	C37H42F2N8O4	468595	Major		Inter Info	[8], [9], [10]
D1541		Telaprevir	C36H53N7O6	3010818	Major		Inter Info	[8], [9], [10]
D1544		Telithromycin	C43H65N5O10	3002190	Major		Inter Info	[8], [9], [10]
D1653		Troleandomycin	C41H67NO15	202225	Major		Inter Info	[8], [9], [10]
D1660		Tucatinib	C26H24N8O2	51039094	Major		Inter Info	[8], [9], [10]
D1706		Voriconazole	C16H14F3N5O	71616	Major		Inter Info	[8], [9], [10]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[53], [54], [55]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[60], [61], [62]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[63], [64], [65]
D0740		Grepafloxacin	C19H22FN3O3	72474	Moderate		Inter Info	[66]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[79], [80]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[88]
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[93], [94], [95]
D0171		Berotralstat	C30H26F4N6O	137528262	Moderate		Inter Info	[98]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[115]
D0413		Dalfopristin	C34H50N4O9S	6323289	Moderate		Inter Info	[119]
D0426		Darunavir	C27H37N3O7S	213039	Moderate		Inter Info	[120], [121]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[15], [122]
D0432		Deferasirox	C21H15N3O4	214348	Moderate		Inter Info	[123], [124]
D0534		Dronedarone	C31H44N2O5S	208898	Moderate		Inter Info	[116], [127]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[128]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[4], [132]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[135], [136], [137]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[93], [94], [95]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[140]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[15], [4], [145]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[4], [116], [146]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[147], [148], [149]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[103], [151], [65]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[15], [4], [152]
D0899		Lefamulin	C28H45NO5S	25185057	Moderate		Inter Info	[103], [154], [65]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[155]
D1057		Miconazole	C18H14Cl4N2O	4189	Moderate		Inter Info	[159]
D1063		Mifepristone	C29H35NO2	55245	Moderate		Inter Info	[4], [160], [161]
D1136		Nilotinib	C28H22F3N7O	644241	Moderate		Inter Info	[163], [65]
D1214		Palbociclib	C24H29N7O2	5330286	Moderate		Inter Info	[172]
D1398		Ribociclib	C23H30N8O	44631912	Moderate		Inter Info	[177], [178], [179]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[182]
D1459		Selpercatinib	C29H31N7O3	134436906	Moderate		Inter Info	[183], [65]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[4], [193]
D1709		Voxelotor	C19H19N3O3	71602803	Moderate		Inter Info	[135], [136], [196]
	CYP450 enzyme induction					Drug Num: 30
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0178		Bexarotene	C24H28O2	82146	Moderate		Inter Info	[4], [37], [38]
D1283		Phenytoin	C15H12N2O2	1775	Moderate		Inter Info	[76], [77], [78]
D1453		Secobarbital	C12H18N2O3	5193	Moderate		Inter Info	[81]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[15], [4], [82]
D1652		Troglitazone	C24H27NO5S	5591	Moderate		Inter Info	[85], [86], [87]
D0194		Bosentan	C27H29N5O6S	104865	Moderate		Inter Info	[102], [103], [104]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[102], [107], [103]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[113]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[4], [116], [117]
D0453		Dexamethasone	C22H29FO5	5743	Moderate		Inter Info	[81]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[15], [129]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[130]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[131]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[134]
D0697		Fosphenytoin	C16H15N2O6P	56339	Moderate		Inter Info	[76], [77], [78]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Moderate		Inter Info	[150]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[4], [156]
D1190		Osimertinib	C28H33N7O2	71496458	Moderate		Inter Info	[4], [168]
D1198		Oxcarbazepine	C15H12N2O2	34312	Moderate		Inter Info	[169], [170], [171]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[81]
D1399		Rifabutin	C46H62N4O11	135398743	Moderate		Inter Info	[81]
D1400		Rifampicin	C43H58N4O12	135398735	Moderate		Inter Info	[81]
D1401		Rifapentine	C47H64N4O12	135403821	Moderate		Inter Info	[81]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[15], [4], [82]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[15], [4], [82]
D1502		St. John's Wort	NA	NA	Moderate		Inter Info	[187], [188], [189]
D1538		Tazemetostat	C34H44N4O4	66558664	Moderate		Inter Info	[136], [191]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Moderate		Inter Info	[4], [192]
D0106		Armodafinil	C15H15NO2S	9690109	Minor		Inter Info	[199], [200], [201]
D1081		Modafinil	C15H15NO2S	4236	Minor		Inter Info	[199], [200], [201]
	Competitive inhibition of metabolic enzyme					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0696		Fosnetupitant	C31H35F6N4O5P	71544786	Moderate		Inter Info	[15], [138], [139]
D1127		Netupitant	C30H32F6N4O	6451149	Moderate		Inter Info	[15], [138], [139]
D1476		Sirolimus	C51H79NO13	5284616	Moderate		Inter Info	[184], [185], [65]
D1549		Temsirolimus	C56H87NO16	6918289	Moderate		Inter Info	[184], [185], [65]
Pharmacodynamic additive effects
	Additive immunosuppressive effects					Drug Num: 45
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Major		Inter Info	[1], [2], [3]
D0348		Cladribine	C10H12ClN5O3	20279	Major		Inter Info	[4], [5]
D0614		Etanercept	NA	NA	Major		Inter Info	[1], [2], [3]
D0802		Infliximab	NA	NA	Major		Inter Info	[1], [2], [3]
D1111		Natalizumab	NA	NA	Major		Inter Info	[11]
D0146		Baricitinib	C16H17N7O2S	44205240	Major		Inter Info	[15], [4], [16]
D0304		Certolizumab pegol	NA	NA	Major		Inter Info	[1], [2], [3]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[17]
D0736		Golimumab	NA	NA	Major		Inter Info	[1], [2], [3]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[4], [21]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[15], [24]
D1600		Tofacitinib	C16H20N6O	9926791	Major		Inter Info	[31]
D1666		Upadacitinib	C17H19F3N6O	58557659	Major		Inter Info	[32]
D0032		Alefacept	NA	NA	Moderate		Inter Info	[4], [33], [34]
D0033		Alemtuzumab	NA	NA	Moderate		Inter Info	[35], [36]
D0085		Anakinra	C20H23N5O7S2	146171046	Moderate		Inter Info	[4], [33], [34]
D0553		Efalizumab	NA	NA	Moderate		Inter Info	[56]
D1855		Palifermin	NA	NA	Moderate		Inter Info	[71]
D0136		Azathioprine	C9H7N7O2S	2265	Moderate		Inter Info	[15], [4], [36]
D0246		Canakinumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D0443		Denosumab	NA	NA	Moderate		Inter Info	[36], [125]
D0499		Dimethyl fumarate	C6H8O4	637568	Moderate		Inter Info	[126]
D0507		Diroximel fumarate	C11H13NO6	73330464	Moderate		Inter Info	[126]
D0747		Guselkumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D0875		Ixekizumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1085		Monomethyl fumarate	C5H6O4	5369209	Moderate		Inter Info	[126]
D1140		Niraparib	C19H20N4O	24958200	Moderate		Inter Info	[164]
D1162		Ocrelizumab	NA	NA	Moderate		Inter Info	[165]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[4], [166]
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Moderate		Inter Info	[167]
D1375		Radium Ra 223 dichloride	NA	NA	Moderate		Inter Info	[173]
D1403		Rilonacept	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1410		Risankizumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1422		Roflumilast	C17H14Cl2F2N2O3	449193	Moderate		Inter Info	[4], [180]
D1447		Sarilumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1448		Satralizumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1454		Secukinumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1467		Siltuximab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1487		Sodium phosphate, monobasic (p32)	NA	NA	Moderate		Inter Info	[186]
D1509		Strontium chloride Sr-89	Cl2Sr	5388879	Moderate		Inter Info	[15], [4], [190]
D1583		Tildrakizumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1610		Topotecan	C23H23N3O5	60700	Moderate		Inter Info	[195]
D1671		Ustekinumab	NA	NA	Moderate		Inter Info	[4], [33], [34]
D1720		Zidovudine	C10H13N5O4	35370	Moderate		Inter Info	[15], [4], [197]
	Additive myelosuppressive effects					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[4], [6], [7]
D1443		Samarium (153Sm) lexidronam	Sm	23951	Major		Inter Info	[23]
D0710		Ganciclovir	C9H13N5O4	135398740	Moderate		Inter Info	[15], [4], [143]
D1676		Valganciclovir	C14H22N6O5	135413535	Moderate		Inter Info	[15], [4], [143]
	Additive thrombogenic effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1569		Thalidomide	C13H10N2O4	5426	Major		Inter Info	[28], [29], [30]
	Increased risk of hepatotoxicity					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[18]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[19]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[20]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[22]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[18]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[67], [68], [69]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[67], [68], [69]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[72], [15], [73]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[83], [84]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[72], [15], [73]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[96], [97]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[105], [106]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[72], [15], [73]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[4], [111]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[114]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[4], [157], [158]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[162]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[67], [68], [69]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[174], [175], [176]
	Increased risk of hyponatremia					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0449		Desmopressin	C46H64N14O12S2	5311065	Moderate		Inter Info	[48], [49], [15]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[48], [49], [15]
	Increased risk of peripheral neuropathy					Drug Num: 64
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0193		Bortezomib	C19H25BN4O4	387447	Moderate		Inter Info	[39], [40], [41]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[42], [43], [44]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[42], [43], [44]
D0344		Cisplatin	Cl2H6N2Pt	5702198	Moderate		Inter Info	[42], [43], [44]
D0419		Dapsone	C12H12N2O2S	2955	Moderate		Inter Info	[42], [43], [44]
D0616		Ethambutol	C10H24N2O2	14052	Moderate		Inter Info	[42], [43], [44]
D0821		Interferon alfa-2a, Recombinant	NA	NA	Moderate		Inter Info	[42], [43], [44]
D0822		Interferon alfa-2b	C16H17Cl3I2N3NaO5S	71306834	Moderate		Inter Info	[42], [43], [44]
D0823		Interferon alfacon-1	NA	NA	Moderate		Inter Info	[42], [43], [44]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[42], [43], [44]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[42], [43], [44]
D1237		Peginterferon alfa-2a	NA	NA	Moderate		Inter Info	[42], [43], [44]
D1238		Peginterferon alfa-2b	NA	NA	Moderate		Inter Info	[42], [43], [44]
D1329		Pravastatin	C23H36O7	54687	Moderate		Inter Info	[42], [43], [44]
D0066		Amiodarone	C25H29I2NO3	2157	Moderate		Inter Info	[42], [43], [44]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[42], [43], [44]
D0126		Auranofin	C20H34AuO9PS	24199313	Moderate		Inter Info	[42], [43], [44]
D0127		Aurothioglucose	C6H11AuO5S	454937	Moderate		Inter Info	[42], [43], [44]
D0162		Benznidazole	C12H12N4O3	31593	Moderate		Inter Info	[42], [43], [44]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[42], [43], [44]
D0260		Carboplatin	C6H12N2O4Pt	426756	Moderate		Inter Info	[42], [43], [44]
D0261		Carfilzomib	C40H57N5O7	11556711	Moderate		Inter Info	[42], [43], [44]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[42], [43], [44]
D0380		Colchicine	C22H25NO6	6167	Moderate		Inter Info	[42], [43], [44]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[42], [43], [44]
D0496		Diiodohydroxyquinoline	C9H5I2NO	3728	Moderate		Inter Info	[42], [43], [44]
D0501		Dinutuximab	NA	NA	Moderate		Inter Info	[42], [43], [44]
D0509		Disulfiram	C10H20N2S4	3117	Moderate		Inter Info	[42], [43], [44]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[42], [43], [44]
D0560		Elotuzumab	NA	NA	Moderate		Inter Info	[42], [43], [44]
D0571		Enfortumab vedotin	NA	NA	Moderate		Inter Info	[42], [43], [44]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[42], [43], [44]
D1731		Ethionamide	C8H10N2S	2761171	Moderate		Inter Info	[42], [43], [44]
D0669		Fludarabine	C10H12FN5O4	657237	Moderate		Inter Info	[42], [43], [44]
D0686		Fluvastatin	C24H26FNO4	446155	Moderate		Inter Info	[42], [43], [44]
D0770		Hydralazine	C8H8N4	3637	Moderate		Inter Info	[42], [43], [44]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[42], [43], [44]
D0841		Ipilimumab	NA	NA	Moderate		Inter Info	[42], [43], [44]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[42], [43], [44]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[42], [43], [44]
D0874		Ixazomib	C14H19BCl2N2O4	25183872	Moderate		Inter Info	[42], [43], [44]
D0918		Levodopa	C9H11NO4	6047	Moderate		Inter Info	[42], [43], [44]
D0933		Linezolid	C16H20FN3O4	441401	Moderate		Inter Info	[42], [43], [44]
D1051		Metronidazole	C6H9N3O3	4173	Moderate		Inter Info	[42], [43], [44]
D1113		Naxitamab	NA	NA	Moderate		Inter Info	[42], [43], [44]
D1118		Nelarabine	C11H15N5O5	3011155	Moderate		Inter Info	[42], [43], [44]
D1145		Nitrofurantoin	C8H6N4O5	6604200	Moderate		Inter Info	[42], [43], [44]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[42], [43], [44]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[42], [43], [44]
D1301		Pitavastatin	C25H24FNO4	5282452	Moderate		Inter Info	[42], [43], [44]
D1306		Polatuzumab vedotin	NA	NA	Moderate		Inter Info	[42], [43], [44]
D1312		Pomalidomide	C13H11N3O4	134780	Moderate		Inter Info	[42], [43], [44]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Moderate		Inter Info	[42], [43], [44]
D1452		Secnidazole	C7H11N3O3	71815	Moderate		Inter Info	[42], [43], [44]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[42], [43], [44]
D1479		Sodium aurothiomalate	C4H3AuNa2O4S	22318	Moderate		Inter Info	[42], [43], [44]
D1504		Stavudine	C10H12N2O4	18283	Moderate		Inter Info	[42], [43], [44]
D1543		Telbivudine	C10H14N2O5	159269	Moderate		Inter Info	[42], [43], [44]
D1587		Tinidazole	C8H13N3O4S	5479	Moderate		Inter Info	[42], [43], [44]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[42], [43], [44]
D1623		Trastuzumab emtansine	NA	NA	Moderate		Inter Info	[42], [43], [44]
D1714		Zafirlukast	C31H33N3O6S	5717	Moderate		Inter Info	[42], [43], [44]
D1715		Zalcitabine	C9H13N3O3	24066	Moderate		Inter Info	[39], [96]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[42], [43], [44]
Pharmacodynamic antagonistic effects
	Antagonize the effect of vaccine/toxoid					Drug Num: 23
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1744		Bacillus calmette-guerin substrain tice live antigen	NA	NA	Major		Inter Info	[12], [13], [14]
D1839		Measles virus vaccine live attenuated	NA	NA	Major		Inter Info	[12], [13], [14]
D1849		Mumps virus strain B level jeryl lynn live antigen	NA	NA	Major		Inter Info	[12], [13], [14]
D1881		Rotavirus vaccine	NA	NA	Major		Inter Info	[12], [13], [14]
D1882		Rubella virus vaccine	NA	NA	Major		Inter Info	[12], [13], [14]
D1890		Smallpox (Vaccinia) Vaccine, Live	NA	NA	Major		Inter Info	[25], [15], [26]
D1897		Talimogene laherparepvec	NA	NA	Major		Inter Info	[27]
D1914		Typhoid vaccine (live)	NA	NA	Major		Inter Info	[12], [13], [14]
D1920		Varicella Zoster Vaccine (Recombinant)	NA	NA	Major		Inter Info	[12], [13], [14]
D1922		Yellow Fever Vaccine	NA	NA	Major		Inter Info	[12], [13], [14]
D1838		Lyme disease vaccine (recombinant OspA)	NA	NA	Moderate		Inter Info	[70]
D0089		Anthrax vaccine	NA	NA	Moderate		Inter Info	[25], [91], [92]
D0366		Clostridium tetani toxoid antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[25], [91], [92]
D0755		Hepatitis A Vaccine	NA	NA	Moderate		Inter Info	[25], [91], [92]
D0756		Hepatitis B Vaccine (Recombinant)	NA	NA	Moderate		Inter Info	[25], [91], [92]
D0767		Human papillomavirus type 11 L1 capsid protein antigen	NA	NA	Moderate		Inter Info	[25], [91], [92]
D0803		Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)	NA	NA	Moderate		Inter Info	[25], [91], [92]
D0804		Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[25], [91], [92]
D0999		Meningococcal polysaccharide vaccine group C	NA	NA	Moderate		Inter Info	[25], [91], [92]
D1259		Pfizer-BioNTech Covid-19 Vaccine	NA	NA	Moderate		Inter Info	[25], [91], [92]
D1307		Poliovirus type 1 antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[25], [91], [92]
D1662		Typhoid vaccine (inactivated)	NA	NA	Moderate		Inter Info	[25], [91], [92]
D1692		Vibrio cholerae CVD 103-HgR strain live antigen	NA	NA	Moderate		Inter Info	[25], [91], [92]
	Antagonize the effect of probiotics					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1749		Bifidobacterium longum infantis	NA	NA	Moderate		Inter Info	[99], [100], [101]
D1827		Lactobacillus acidophilus	NA	NA	Moderate		Inter Info	[99], [100], [101]
	Diminish the response to diagnostic skin test antigens					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1755		Candida albicans	C29H27N2O12P	118855431	Moderate		Inter Info	[108], [109], [110]
D1765		Coccidioides immitis spherule	NA	NA	Moderate		Inter Info	[108], [109], [110]
D1912		Trichophyton mentagrophytes	NA	NA	Moderate		Inter Info	[108], [109], [110]
D1913		Tuberculin purified protein derivative	NA	NA	Moderate		Inter Info	[108], [109], [110]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0659		Filgrastim	NA	NA	Moderate		Inter Info	[57], [58], [59]
D1235		Pegfilgrastim	C27H46N4O19	70683024	Moderate		Inter Info	[74], [75]
D1446		Sargramostim	NA	NA	Moderate		Inter Info	[57], [58], [59]

References
1	Product Information. Cimzia (certolizumab). UCB Pharma Inc, Smyrna, GA.
2	Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
3	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Drug labels for the Tumor Necrosis Factor-alpha (TNFa) blockers now include warnings about infection with Legionella and Listeria bacteria. ".
4	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
5	Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
6	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
7	Canadian Pharmacists Association "e-CPS."
8	Bermudez M, Fuster JL, Llinares E, Galera A, Gonzalez C "Itraconazole-related increased vincristine neurotoxicity: case report and review of literature." J Pediatr Hematol Oncol 27 (2005): 389-392. [PMID: 16012330]
9	Porter CC, Carver AE, Albano EA "Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X." Pediatr Blood Cancer 52 (2009): 298-300. [PMID: 18837430]
10	Product Information. Velban (vinblastine). Lilly, Eli and Company, Indianapolis, IN.
11	Product Information. Tysabri (natalizumab). Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.
12	Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998).
13	Product Information. Attenuvax (measles virus vaccine, live, attenuated). Merck &amp Co, Inc, West Point, PA.
14	Product Information. YF-Vax (yellow fever vaccine). sanofi pasteur, Swiftwater, PA.
15	Cerner Multum, Inc. "Australian Product Information.".
16	Product Information. Olumiant (baricitinib). Lilly, Eli and Company, Indianapolis, IN.
17	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
18	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
19	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
20	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
21	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
22	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
23	Product Information. Quadramet (samarium sm 153 lexidronam) Berlex Laboratories, Richmond, CA.
24	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
25	CDC. Centers for Disease Control and Prevention/ "Recommendations of the advisory committtee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence." MMWR Morb Mortal Wkly Rep 42(RR-04) (1993): 1-18. [PMID: 20300058]
26	Product Information. Dryvax (smallpox vaccine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
27	Product Information. Imlygic (talimogene laherparepvec). Amgen USA, Thousand Oaks, CA.
28	Figg WD, Arlen P, Gulley J, et al. "A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer." Semin Oncol 28(4 Suppl 15) (2001): 62-6. [PMID: 11685731]
29	Fine HA, Wen PY, Maher EA, et al. "Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas." J Clin Oncol 21 (2003): 2299-304. [PMID: 12805330]
30	Zangari M, Siegel E, Barlogie B, et al "Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy." Blood 100 (2002): 1168-71. [PMID: 12149193]
31	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
32	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
33	Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
34	Product Information. Sylvant (siltuximab). Janssen Biotech, Inc., Horsham, PA, PA.
35	Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
36	Product Information. Lonsurf (tipiracil-trifluridine). Taiho Oncology, Inc., Princeton, NJ.
37	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
38	Wakelee HA, Takimoto CH, Lopez-Anaya A, et al. "The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer." Cancer Chemother Pharmacol 69 (2012): 563-71. [PMID: 22057855]
39	Argov Z, Mastaglia FL "Drug-induced peripheral neuropathies." Br Med J 1 (1979): 663-6. [PMID: 219931]
40	Cavaletti G, Jakubowiak AJ "Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies." Leuk Lymphoma 51 (2010): 1178-87. [PMID: 20497001]
41	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
42	Carrion C, Espinosa E, Herrero A, Garcia B "Possible vincristine-isoniazid interaction." Ann Pharmacother 29 (1995): 201. [PMID: 7756727]
43	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
44	Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online."
45	Cowie F, Pinkerton CR "Enhanced toxicity of dactinomycin and vincristine by cyclosporine given to reverse multidrug resistance." J Clin Oncol 12 (1994): 1998-9. [PMID: 8083726]
46	Ducharme MP, Warbasse LH, Edwards DJ "Disposition of intravenous and oral cyclosporine after administration with grapefruit juice." Clin Pharmacol Ther 57 (1995): 485-91. [PMID: 7768070]
47	Min DI, Ku YM, Perry PJ, Ukah FO, Ashton K, Martin MF, Hunsicker LG "Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients." Transplantation 62 (1996): 123-5. [PMID: 8693526]
48	Vanhees SL, Paridaens R, Vansteenkiste JF "Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review." Ann Oncol 11 (2000): 1061-5. [PMID: 11038047]
49	Kosmidis HV, Bouhoutsou DO, Varvoutsi MC, et al. "Vincristine overdose: experience with 3 patients." Pediatr Hematol Oncol 8 (1991): 171-8. [PMID: 1863543]
50	Bjornsson TD, Huang AT, Roth P, Jacob DS, Christenson R "Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations." Clin Pharmacol Ther 39 (1986): 25-8. [PMID: 3943266]
51	Kuhlmann J, Wilke J, Rietbrock N "Cytostatic drugs are without significant effect on digitoxin plasma level and renal excretion." Clin Pharmacol Ther 32 (1982): 646-51. [PMID: 6897028]
52	Product Information. Lanoxicaps (digoxin). Glaxo Wellcome, Research Triangle Park, NC.
53	Renton KW "Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil." Biochem Pharmacol 34 (1985): 2549-53. [PMID: 4015695]
54	Sakai H, Kobayashi S, Hamada K, et al "The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates." Br J Clin Pharmacol 31 (1991): 353-5. [PMID: 2054276]
55	Sutton D, Butler AM, Nadin L, Murray M "Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites." J Pharmacol Exp Ther 282 (1997): 294-300. [PMID: 9223567]
56	Product Information. Raptiva (efalizumab). Genentech, South San Francisco, CA.
57	Product Information. Granix (tbo-filgrastim). Teva Pharmaceuticals USA, North Wales, PA.
58	Product Information. Leukine (sargramostim). Immunex Corporation, Seattle, WA.
59	Product Information. Stemgen (ancestim) Amgen, Thousand Oaks, CA.
60	Assan R, Fredj G, Larger E, Feutren G, Bismuth H "FK 506/fluconazole interaction enhances FK 506 nephrotoxicity." Diabete Metab 20 (1994): 49-52. [PMID: 7520007]
61	Sinofsky FE, Pasquale SA "The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives." Am J Obstet Gynecol 178 (1998): 300-4. [PMID: 9500490]
62	Ulivelli M, Rubegni P, Nuti D, Bartalini S, Giannini F, Rossi S "Clinical evidence of fluconazole-induced carbamazepine toxicity." J Neurol 251 (2004): 622-3. [PMID: 15164201]
63	Damkier P, Hansen LL, Brosen K "Effect of fluvoxamine on the pharmacokinetics of quinidine." Eur J Clin Pharmacol 55 (1999): 451-6. [PMID: 10492058]
64	Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
65	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
66	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
67	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
68	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
69	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
70	Shen AK, Mead PS, Beard CB. The Lyme disease vaccine--a public health perspective. Clin Infect Dis. 2011;52 Suppl 3:s247-s252. [PMID: 21217171]
71	Product Information. Kepivance (palifermin). Shire US Inc, Florence, KY.
72	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
73	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
74	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
75	Product Information. Neulasta (pegfilgrastim). Amgen, Thousand Oaks, CA.
76	Jarosinski PF, Moscow JA, Alexander MS, et al "Altered phenytoin clearance during intensive chemotherapy for acute lymphoblastic leukemia." J Pediatr 112 (1988): 996-9. [PMID: 3163735]
77	Product Information. Oncovin (vincristine). Lilly, Eli and Company, Indianapolis, IN.
78	Sylvester RK, Lewis FB, Caldwell KC, Lobell M, Perri R, Sawchuk RA "Impaired phenytoin bioavailability secondary to cisplantin, vinblastine, and bleomycin." Ther Drug Monit 6 (1984): 302-5. [PMID: 6209833]
79	Pierce DA, Reeves-Daniel AM "Ranolazine-tacrolimus interaction." Ann Pharmacother 44 (2010): 1844-9. [PMID: 20876828]
80	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
81	Product Information. Marqibo (vinCRIStine liposome). Talon Therapeutics Inc, South San Francisco,, CA.
82	Product Information. Zorbtive (somatropin). Serono Laboratories Inc, Rockland, MA.
83	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
84	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
85	Fraser CG, Fierro L "Comment: troglitazone." Ann Pharmacother 32 (1998): 1111-2. [PMID: 9793612]
86	Park MH, Pelegrin D, Haug MT, Young JB "Troglitazone, a new antidiabetic agent, decreases cyclosporine level." J Heart Lung Transplant 17 (1998): 1139-40. [PMID: 9855455]
87	Product Information. Rezulin (troglitazone). Parke-Davis, Morris Plains, NJ.
88	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
89	Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
90	Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
91	Product Information. Imovax Rabies (rabies vaccine). sanofi pasteur, Swiftwater, PA.
92	Department of Health. National Health Service "Immunisation Against Infectious Disease - "The Green Book". Chapter 6: Contraindications and special considerations.".
93	Charasson V, Haaz MC, Robert J "Determination of Drug Interactions Occurring with the Metabolic Pathways of Irinotecan." Drug Metab Dispos 30 (2002): 731-733. [PMID: 12019202]
94	Clarke SJ, Rivory LP "Clinical pharmacokinetics of docetaxel." Clin Pharmacokinet 36 (1999): 99-114. [PMID: 10092957]
95	Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P, Rahmani R "Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions." Biochem Pharmacol 45 (1993): 853-61. [PMID: 8452560]
96	Product Information. Hivid (zalcitabine). Roche Laboratories, Nutley, NJ.
97	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
98	Product Information. Orladeyo (berotralstat). BioCryst Pharmaceuticals Inc, Durham, NC.
99	Borriello SP, Hammes WP, Holzapfel W, et.al "Safety of probiotics that contain lactobacilli or bifidobacteria." Clin Infect Dis 36 (2003): 775-80. [PMID: 12627362]
100	Schlegel L, Lemerle S, Geslin P "Lactobacillus species as opportunistic pathogens in immunocompromised patients." Eur J Clin Microbiol Infect Dis 17 (1998): 887-8. [PMID: 10052559]
101	Salminen MK, Tynkkynen S, Rautelin H, et al. "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis 35 (2002): 1155-60. [PMID: 12410474]
102	Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):.
103	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
104	Product Information. Tracleer (bosentan). Acetelion Pharmaceuticals US, Inc, South San Francisco, CA.
105	Product Information. Accolate (zafirlukast). Zeneca Pharmaceuticals, Wilmington, DE.
106	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
107	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
108	Product Information. Tuberculin PPD (Mantoux) (tuberculin purified protein derivative). Connaught Laboratories Ltd, Toronto, ON.
109	Product Information. Candin (candida albicans extract). Nielsen Biosciences Inc, San Diego, CA.
110	Product Information. Spherulin (coccidioidin skin test). ALK Laboratories Inc, Wallingford, CT.
111	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
112	Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
113	Product Information. Xcopri (cenobamate). SK Life Science, Inc., Paramus, NJ.
114	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
115	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
116	Product Information. Ambien (zolpidem). sanofi-aventis, Bridgewater, NJ.
117	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
118	Product Information. Daklinza (daclatasvir). Bristol-Myers Squibb, Princeton, NJ.
119	Product Information. Synercid (dalfopristin-quinupristin) Rhone-Poulenc Rorer, Collegeville, PA.
120	Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
121	Schubert W, Eriksson U, Edgar B, Cullberg G, Hedner T "Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17B-estradiol." Eur J Drug Metab Pharmacokinet 20 (1995): 219-24. [PMID: 8751044]
122	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
123	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
124	Skerjanec A, Wang J, Maren K, Rojkjaer L "Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers." J Clin Pharmacol 50 (2010): 205-13. [PMID: 19940232]
125	Product Information. Prolia (denosumab). Amgen USA, Thousand Oaks, CA.
126	Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.
127	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
128	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
129	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
130	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
131	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
132	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
133	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
134	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
135	Bailey DG, Arnold JMO, Spence JD "Grapefruit juice and drugs - how significant is the interaction." Clin Pharmacokinet 26 (1994): 91-8. [PMID: 8162660]
136	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
137	Product Information. Inrebic (fedratinib). Celgene Corporation, Summit, NJ.
138	Product Information. Akynzeo (netupitant-palonosetron). Eisai Inc, Woodcliff Lake, NJ.
139	Product Information. Akynzeo for Injection (fosnetupitant-palonosetron). Helsinn Therapeutics Inc, Woodbridge Township, NJ.
140	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
141	Product Information. Multihance (gadobenate dimeglumine). Bracco Diagnostics Inc, Princeton, NJ.
142	Huisman MT, Smit JW, Crommentuyn KM, et al. "Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs." AIDS 16 (2002): 2295-2301. [PMID: 12441801]
143	Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
144	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
145	Product Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals, East Hanover, NJ.
146	Product Information. Cresemba (isavuconazonium). Astellas Pharma US, Inc, Deerfield, IL.
147	Lilja JJ, Kivisto KT, Neuvonen PJ "Grapefruit juice-simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors." Clin Pharmacol Ther 64 (1998): 477-83. [PMID: 9834039]
148	Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
149	Richter WO, Jacob BG, Schwandt P "Interaction between fibre and lovastatin." Lancet 338 (1991): 706. [PMID: 1679514]
150	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
151	Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
152	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
153	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
154	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
155	Product Information. Prevymis (letermovir). Merck &amp Company Inc, Whitehouse Station, NJ.
156	Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
157	Nesher G, Mates M, Zevin S "Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis." Arthritis Rheum 48 (2003): 571-572. [PMID: 12571869]
158	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
159	Product Information. ORAVIG (miconazole). Strativa Pharmaceuticals, a Division of Par Pharmaceuticals, Inc., Woodcliff Lake, NJ.
160	He K, Woolf TF, Hollenberg PF "Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486)." J Pharmacol Exp Ther 288 (1999): 791-7. [PMID: 9918590]
161	Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
162	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
163	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
164	Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.
165	Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
166	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
167	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
168	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
169	Product Information. Trileptal (oxcarbazepine) Novartis Pharmaceuticals, East Hanover, NJ.
170	Rosche J, Froscher W, Abendroth D, Liebel J "Possible oxcarbazepine interaction with cyclosporine serum levels: A single case study." Clin Neuropharmacol 24 (2001): 113-6. [PMID: 11307049]
171	Zaccara G, Gangemi PF, Bendoni L, Menge GP, Schwabe S, Monza GC "Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodipine." Ther Drug Monit 15 (1993): 39-42. [PMID: 8451779]
172	Product Information. Ibrance (palbociclib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
173	Product Information. Xofigo (radium Ra 223 dichloride). Bayer Pharmaceutical Inc, West Haven, CT.
174	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
175	Gilead Sciences, Inc "About Remdesivir.".
176	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
177	Kane GC, Lipsky JJ "Drug-grapefruit juice interactions." Mayo Clin Proc 75 (2000): 933-42. [PMID: 10994829]
178	Rawden HC, Kokwaro GO, Ward SA, Edwards G "Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes." Br J Clin Pharmacol 49 (2000): 313-22. [PMID: 10759686]
179	Trivier JM, Libersa C, Belloc C, Lhermitte M "Amiodarone N-deethylation in human liver microsomes: involvement of cytochrome P450 3A enzymes (first report)." Life Sci 52 (1993): pl91-6. [PMID: 8445979]
180	Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
181	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
182	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
183	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
184	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
185	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
186	AnazaoHealth Corporation "P32 Sodium Phosphate."
187	Patel S, Robinson R, Burk M "Hypertensive crisis associated with St. John's Wort." Am J Med 112 (2002): 507-8. [PMID: 11959071]
188	Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH "St John's Wort: Effect on CYP3A4 activity." Clin Pharmacol Ther 67 (2000): 451-7. [PMID: 10824623]
189	Sparreboom A, Cox MC, Acharya MR, Figg WD "Herbal remedies in the United States: potential adverse interactions with anticancer agents." J Clin Oncol 22 (2004): 2489-503. [PMID: 15197212]
190	Multum Information Services, Inc. Expert Review Panel.
191	Product Information. Tazverik (tazemetostat). Epizyme, Inc, Cambridge, MA.
192	Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
193	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
194	Product Information. Jynarque (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
195	Product Information. Hycamtin (topotecan). SmithKline Beecham, Philadelphia, PA.
196	Product Information. Oxbryta (voxelotor). Global Blood Therapeutics, Inc., South San Francisco, CA.
197	Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.
198	Johnson EJ, MacGowan AP, Potter MN, et al "Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy." J Antimicrob Chemother 25 (1990): 837-42. [PMID: 2373666]
199	Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
200	Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
201	Robertson P Jr, Hellriegel ET, Arora S, Nelson M "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers." Clin Pharmacol Ther 71 (2002): 46-56. [PMID: 11823757]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence